Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Macrolide ºÒÀÀ¼º ¸¶ÀÌÄÚÇöóÁ Æó·Å°ú ÀûÇ÷±¸Æ÷½Ä¸²ÇÁÁ¶Á÷±¸Áõ: Áõ·Êº¸°í¿Í ¹®Çå°íÂû Macrolide-refractory Mycoplasma pneumoniae pneumonia and hemophagocytic lymphohistiocytosis: case report and literature review

´ëÇѼҾÆÀÀ±ÞÀÇÇÐȸÁö 2020³â 7±Ç 2È£ p.145 ~ 150
¸¶¼º¿¬, ±è´Üºñ, ÀÌÁÖ¿µ, Á¶°æ¼ø, ¼­Áø¼ø, À̼ö¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
¸¶¼º¿¬ ( Ma Sung-Yun ) 
Catholic University College of Medicine Department of Pediatrics

±è´Üºñ ( Kim Dan-Bi ) 
Catholic University College of Medicine Department of Pediatrics
ÀÌÁÖ¿µ ( Lee Ju-Young ) 
Catholic University College of Medicine Department of Pediatrics
Á¶°æ¼ø ( Cho Kyoung-Soon ) 
Catholic University College of Medicine Department of Pediatrics
¼­Áø¼ø ( Suh Jin-Soon ) 
Catholic University College of Medicine Department of Pediatrics
À̼ö¿µ ( Lee Soo-Young ) 
Catholic University College of Medicine Department of Pediatrics

Abstract


Mycoplasma pneumoniae causes various extra-pulmonary complications. As a rare but fatal hematological complication, hemophagocytic lymphohistiocytosis (HLH) can be observed in children with M. pneumoniae infection. We report a case of a 6-year-old girl with HLH who was initially presumed to have macrolide-refractory M. pneumoniae pneumonia. Despite the combination treatment of antimicrobial and anti-inflammatory agents, she showed persistent fever, hepatosplenomegaly, and thrombocytopenia. Secondary HLH associated with M. pneumoniae should be considered if unexplained clinical deterioration is noted in children with macrolide-refractory M. pneumoniae pneumonia.

Å°¿öµå

Child; Lymphohistiocytosis, Hemophagocytic; Macrolides; Mycoplasma pneumoniae; Treatment Failure

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed